These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24556643)

  • 1. Antiangiogenic therapy inhibits the recruitment of vascular accessory cells to the perivascular niche in glioma angiogenesis.
    Parmaksız G; Czabanka M; Vinci M; Vajkoczy P
    J Vasc Res; 2014; 51(2):102-9. PubMed ID: 24556643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. F8-SIP mediated targeted photodynamic therapy leads to microvascular dysfunction and reduced glioma growth.
    Acker G; Palumbo A; Neri D; Vajkoczy P; Czabanka M
    J Neurooncol; 2016 Aug; 129(1):33-8. PubMed ID: 27188647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NDRG1 overexpressing gliomas are characterized by reduced tumor vascularization and resistance to antiangiogenic treatment.
    Broggini T; Wüstner M; Harms C; Stange L; Blaes J; Thomé C; Harms U; Mueller S; Weiler M; Wick W; Vajkoczy P; Czabanka M
    Cancer Lett; 2016 Oct; 380(2):568-576. PubMed ID: 26297987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EphB4 mediates resistance to antiangiogenic therapy in experimental glioma.
    Uhl C; Markel M; Broggini T; Nieminen M; Kremenetskaia I; Vajkoczy P; Czabanka M
    Angiogenesis; 2018 Nov; 21(4):873-881. PubMed ID: 29987450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors.
    Folkins C; Man S; Xu P; Shaked Y; Hicklin DJ; Kerbel RS
    Cancer Res; 2007 Apr; 67(8):3560-4. PubMed ID: 17440065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementary information from magnetic resonance imaging and (18)F-fluoromisonidazole positron emission tomography in the assessment of the response to an antiangiogenic treatment in a rat brain tumor model.
    Valable S; Petit E; Roussel S; Marteau L; Toutain J; Divoux D; Sobrio F; Delamare J; Barré L; Bernaudin M
    Nucl Med Biol; 2011 Aug; 38(6):781-93. PubMed ID: 21843775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined inhibition of vascular endothelial growth factor and platelet-derived growth factor signaling: effects on the angiogenesis, microcirculation, and growth of orthotopic malignant gliomas.
    Farhadi MR; Capelle HH; Erber R; Ullrich A; Vajkoczy P
    J Neurosurg; 2005 Feb; 102(2):363-70. PubMed ID: 15739567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sunitinib impedes brain tumor progression and reduces tumor-induced neurodegeneration in the microenvironment.
    Hatipoglu G; Hock SW; Weiss R; Fan Z; Sehm T; Ghoochani A; Buchfelder M; Savaskan NE; Eyüpoglu IY
    Cancer Sci; 2015 Feb; 106(2):160-70. PubMed ID: 25458015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravital microscopy reveals novel antivascular and antitumor effects of endostatin delivered locally by alginate-encapsulated cells.
    Read TA; Farhadi M; Bjerkvig R; Olsen BR; Rokstad AM; Huszthy PC; Vajkoczy P
    Cancer Res; 2001 Sep; 61(18):6830-7. PubMed ID: 11559558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sunitinib on tumor hemodynamics and delivery of chemotherapy.
    Czabanka M; Vinci M; Heppner F; Ullrich A; Vajkoczy P
    Int J Cancer; 2009 Mar; 124(6):1293-300. PubMed ID: 19101989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting angiogenesis inhibits tumor infiltration and expression of the pro-invasive protein SPARC.
    Vajkoczy P; Menger MD; Goldbrunner R; Ge S; Fong TA; Vollmar B; Schilling L; Ullrich A; Hirth KP; Tonn JC; Schmiedek P; Rempel SA
    Int J Cancer; 2000 Jul; 87(2):261-8. PubMed ID: 10861485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined temozolomide and sunitinib treatment leads to better tumour control but increased vascular resistance in O6-methylguanine methyltransferase-methylated gliomas.
    Czabanka M; Bruenner J; Parmaksiz G; Broggini T; Topalovic M; Bayerl SH; Auf G; Kremenetskaia I; Nieminen M; Jabouille A; Mueller S; Harms U; Harms C; Koch A; Heppner FL; Vajkoczy P
    Eur J Cancer; 2013 Jun; 49(9):2243-52. PubMed ID: 23499430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging biomarker dynamics in an intracranial murine glioma study of radiation and antiangiogenic therapy.
    Chung C; Jalali S; Foltz W; Burrell K; Wildgoose P; Lindsay P; Graves C; Camphausen K; Milosevic M; Jaffray D; Zadeh G; Ménard C
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):805-12. PubMed ID: 22929856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects.
    Abdollahi A; Lipson KE; Sckell A; Zieher H; Klenke F; Poerschke D; Roth A; Han X; Krix M; Bischof M; Hahnfeldt P; Grone HJ; Debus J; Hlatky L; Huber PE
    Cancer Res; 2003 Dec; 63(24):8890-8. PubMed ID: 14695206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of angiogenesis inhibition by sunitinib on tumor distribution of temozolomide.
    Zhou Q; Guo P; Gallo JM
    Clin Cancer Res; 2008 Mar; 14(5):1540-9. PubMed ID: 18316579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential efficacy of SSTR1, -2, and -5 agonists in the inhibition of C6 glioma growth in nude mice.
    Barbieri F; Pattarozzi A; Gatti M; Aiello C; Quintero A; Lunardi G; Bajetto A; Ferrari A; Culler MD; Florio T
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1078-88. PubMed ID: 19706788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of sunitinib on the distribution of temozolomide in an orthotopic glioma model.
    Zhou Q; Gallo JM
    Neuro Oncol; 2009 Jun; 11(3):301-10. PubMed ID: 18971416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescent diagnosis and photodynamic therapy for C6 glioma in combination with antiangiogenic therapy in subcutaneous and intracranial tumor models.
    Tzerkovsky DA; Osharin VV; Istomin YP; Alexandrova EN; Vozmitel MA
    Exp Oncol; 2014 Jun; 36(2):85-9. PubMed ID: 24980761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of the fibrinolytic system by cartilage extract mediates its antiangiogenic effect in mouse glioma.
    Simard B; Bouamrani A; Jourdes P; Pernod G; Dimitriadou V; Berger F
    Microvasc Res; 2011 Jul; 82(1):6-17. PubMed ID: 21406197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of glioma formation: iterative perivascular glioma growth and invasion leads to tumor progression, VEGF-independent vascularization, and resistance to antiangiogenic therapy.
    Baker GJ; Yadav VN; Motsch S; Koschmann C; Calinescu AA; Mineharu Y; Camelo-Piragua SI; Orringer D; Bannykh S; Nichols WS; deCarvalho AC; Mikkelsen T; Castro MG; Lowenstein PR
    Neoplasia; 2014 Jul; 16(7):543-61. PubMed ID: 25117977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.